Milliken Laura A, Wilhelmy Jennifer, Martin Catherine J, Finkenthal Nuris, Cussler Ellen, Metcalfe Lauve, Guido Terri Antoniotti, Going Scott B, Lohman Timothy G
Department of Exercise and Health Sciences, University of Massachusetts, Boston, 100 Morrissey Blvd., Boston, MA 02125, USA.
J Gerontol A Biol Sci Med Sci. 2006 May;61(5):488-94. doi: 10.1093/gerona/61.5.488.
Lower bone mineral density (BMD) has been documented in clinically depressed populations, and depression is the second most common chronic medical condition in general medical practice. Therefore, the purpose of this study was to determine whether depressive symptoms, vitality, and body weight changes were related to 1-year BMD changes after accounting for covariates.
Healthy postmenopausal women (n=320; 40-65 years) were recruited, and 266 women completed the study. Participants were 3-10 years postmenopausal, sedentary, and either taking hormone replacement therapy (1-3.9 years) or not taking it (at least 1 year). Exclusion criteria were: current smoking status, history of fractures, low BMD, body mass index>32.9 or <19.0, or use of bone altering medications. Regional BMD was measured from dual-energy x-ray absorptiometry at baseline and 1 year. Self-reported depressive symptoms and vitality were measured using standard questionnaires.
Both the vitality and depressive symptoms scores were related to BMD changes at the femur neck but not at the greater trochanter or spine. Weight change was a predictor of BMD changes in the trochanter and spine but not in the femoral neck. Weight change and vitality and/or depressive symptoms had differential and site-specific effects on BMD changes at the hip. Vitality and depressive symptoms related to femoral neck changes and weight change related to greater trochanter changes.
The negative impact of depressive symptoms on BMD in this population of postmenopausal women was independent of body weight or other behavioral factors such as calcium compliance or exercise.
临床抑郁症患者中已证实存在较低的骨矿物质密度(BMD),且抑郁症是普通医疗实践中第二常见的慢性疾病。因此,本研究的目的是在考虑协变量后,确定抑郁症状、活力和体重变化是否与1年的骨密度变化相关。
招募健康的绝经后女性(n = 320;40 - 65岁),266名女性完成了研究。参与者绝经3 - 10年,久坐不动,正在接受激素替代疗法(1 - 3.9年)或未接受(至少1年)。排除标准为:当前吸烟状况、骨折史、低骨密度、体重指数>32.9或<19.0,或使用影响骨骼的药物。在基线和1年时通过双能X线吸收法测量局部骨密度。使用标准问卷测量自我报告的抑郁症状和活力。
活力和抑郁症状评分均与股骨颈的骨密度变化有关,但与大转子或脊柱无关。体重变化是大转子和脊柱骨密度变化的预测因素,但不是股骨颈骨密度变化的预测因素。体重变化、活力和/或抑郁症状对髋部骨密度变化具有不同的部位特异性影响。活力和抑郁症状与股骨颈变化有关,体重变化与大转子变化有关。
在这群绝经后女性中,抑郁症状对骨密度的负面影响独立于体重或其他行为因素,如钙摄入量或运动。